Cipher Pharmaceuticals Inc.
CPHRF
$10.44
$0.242.35%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.83M | 13.38M | 12.02M | 11.82M | 10.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.83M | 13.38M | 12.02M | 11.82M | 10.37M |
| Cost of Revenue | 2.35M | 2.50M | 2.88M | 5.13M | 1.97M |
| Gross Profit | 10.49M | 10.88M | 9.14M | 6.69M | 8.40M |
| SG&A Expenses | 3.71M | 4.09M | 4.82M | 4.85M | 4.61M |
| Depreciation & Amortization | 1.80M | 1.81M | 1.82M | 1.51M | 1.93M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.86M | 8.39M | 9.55M | 11.49M | 8.50M |
| Operating Income | 4.97M | 4.99M | 2.47M | 334.00K | 1.87M |
| Income Before Tax | 4.26M | 6.41M | 1.89M | -2.85M | 326.00K |
| Income Tax Expenses | -1.24M | 512.00K | -737.00K | -6.20M | 43.00K |
| Earnings from Continuing Operations | 5.50M | 5.89M | 2.62M | 3.34M | 283.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.50M | 5.89M | 2.62M | 3.34M | 283.00K |
| EBIT | 4.97M | 4.99M | 2.47M | 334.00K | 1.87M |
| EBITDA | 6.77M | 6.80M | 4.30M | 1.67M | 3.80M |
| EPS Basic | 0.22 | 0.23 | 0.10 | 0.13 | 0.01 |
| Normalized Basic EPS | 0.10 | 0.15 | 0.05 | -0.05 | 0.05 |
| EPS Diluted | 0.21 | 0.22 | 0.10 | 0.13 | 0.01 |
| Normalized Diluted EPS | 0.10 | 0.15 | 0.05 | -0.05 | 0.05 |
| Average Basic Shares Outstanding | 25.37M | 25.87M | 25.61M | 25.72M | 25.17M |
| Average Diluted Shares Outstanding | 25.95M | 26.51M | 26.20M | 25.72M | 25.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |